Dr. Cho is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
160 E 34th St
New York, NY 10016Phone+1 212-731-5445Fax+1 718-731-5545
Education & Training
- Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2000 - 2003
- Washington University in St. Louis School of MedicineClass of 2000
Certifications & Licensure
- NY State Medical License 2013 - 2025
- MA State Medical License 2002 - 2015
Publications & Presentations
PubMed
- 192 citationsPreliminary results for avelumab plus axitinib as first-line therapy in patients with advanced clear-cell renal-cell carcinoma (JAVELIN Renal 100): an open-label, dose...Toni K. Choueiri, James Larkin, Mototsugu Oya, Fiona C Thistlethwaite, Marcella Martignoni
The Lancet. Oncology. 2018-04-01 - 16 citationsBempegaldesleukin plus nivolumab in first-line renal cell carcinoma: results from the PIVOT-02 study.Nizar M Tannir, Daniel C Cho, Adi Diab, Mario Sznol, Mehmet A Bilen
Journal for Immunotherapy of Cancer. 2022-04-01 - 30 citationsFirst-in-human phase I/II, open-label study of the anti-OX40 agonist INCAGN01949 in patients with advanced solid tumors.Elizabeth J Davis, Juan Martin-Liberal, Rebecca Kristeleit, Daniel C Cho, Sarah P Blagden
Journal for Immunotherapy of Cancer. 2022-10-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: